Next Generation Sequencing (NGS)
Medconnect Vienna provides access to a wide range of modern diagnostic and therapeutic services. These include, among others, genetic analyses using Next Generation Sequencing (NGS). These innovative tests enable precise and personalized diagnostics and support physicians in making well-founded treatment decisions.
What is Next Generation Sequencing?
Next Generation Sequencing (NGS) is a state-of-the-art genetic analysis method that allows multiple genes to be examined simultaneously. Compared to conventional genetic tests, NGS enables a particularly fast, detailed, and comprehensive analysis of genetic material.
NGS is primarily used when:
- complex or unclear clinical conditions are present,
- a genetic cause is suspected,
- personalized therapy planning is required,
- or targeted treatment decisions (e.g. in oncology) need to be supported.
The main advantage of NGS lies in its high diagnostic value, as genetic alterations can be detected early and interpreted in a targeted manner.
Benefits of NGS testing
NGS analyses are used, among other things, in:
• oncological diagnostics (e.g. tumor genetics)
• rare or hereditary diseases
• neurological and internal medicine conditions
• individualized therapy and medication selection
Test results are usually available within one week, allowing for prompt planning of further medical treatment.
Gene panel tests – targeted genetic diagnostics
A gene panel test is a specific form of NGS analysis in which selected genes associated with a particular disease or clinical question are examined in a targeted manner.
Gene panel tests are particularly useful:
• in cases of clearly defined symptoms or suspected diagnoses
• when specific diseases need to be confirmed or ruled out
• for risk assessment in hereditary conditions
• or to support tailored therapy decisions